Who is Seeking Traditional Chinese Medicine (TCM) for Cancer? Insights from a Large Cohort in a Rehabilitation Clinic
Open Access
- 1 April 2025
- journal article
- research article
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 19, 883-896
Abstract
Purpose: Traditional Chinese Medicine (TCM) is widely used in cancer care, yet its utilization features are not well understood. By providing a comprehensive overview of the demographic and clinical characteristics, symptom burden, HRQoL, and TCM constitution of cancer patients seeking TCM treatment, we aim to offer insights into the integration of TCM into cancer care. Patients and Methods: The questionnaire collected data on demographic and clinical characteristics, the MD Anderson Symptom Inventory for Traditional Chinese Medicine (MDASI-TCM), the EuroQol-5Dimensions-5Levels (EQ-5D-5L), and the simplified version of the Constitution in Chinese Medicine Questionnaire (CCMQ). A descriptive analysis was conducted to profile the patients’ status and expectations of TCM. Chi-square or Fisher exact tests were employed to compare the distribution of TCM constitutional types across different cancer diagnoses. Results: Among 3047 eligible patients, 2796 (median age 55) completed the questionnaire and were subsequently included in the analysis. The cohort was predominantly female (56.5%), with lung cancer being the most common primary diagnosis (25.2%). Furthermore, 86.7% of the patients presented with a good performance status (ECOG-PS ≤ 1). The main reasons patients sought TCM treatment were to alleviate cancer-related symptoms (59.4%) and enhance immune function (55.4%). The most prevalent symptoms (scored 1– 10 on a 0– 10 scale) were fatigue (81.1%), followed by disturbed sleep (81.0%), and dry mouth (78.2%). The mean and median EQ-5D-5L utility scores were 0.81 and 0.89, respectively. About 83.4% of cancer patients exhibited a deviation in TCM constitution, with Yang-deficiency being particularly common among them. Conclusion: This study highlights the symptom burden, HRQoL, TCM constitution, and characteristics of patients who pursue TCM treatment. It advances our understanding of TCM’s role in cancer rehabilitation by shedding light on target population potential needs of care. The findings provide a foundation for developing evidence-based strategies to enhance TCM application in clinical settings, optimize resource allocation, and improve rehabilitation outcomes for cancer patients.Keywords
This publication has 61 references indexed in Scilit:
- Use of Chinese Herb Medicine in Cancer Patients: A Survey in Southwestern ChinaEvidence-Based Complementary and Alternative Medicine, 2012
- Translational approaches to treatment-induced symptoms in cancer patientsNature Reviews Clinical Oncology, 2012
- Developing the Chinese version of the new 5-level EQ-5D descriptive system: the response scaling approachQuality of Life Research, 2012
- Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): Searching for StandardsJournal of Pain and Symptom Management, 2010
- Clinical guideline for the evaluation and management of chronic insomnia in adults.2008
- De Qi: Chinese Acupuncture Patients' Experiences and Beliefs regarding Acupuncture Needling Sensation – An Exploratory SurveyAcupuncture in Medicine, 2007
- Investigation of common symptoms of cancer and reliability analysisChinese Journal of Integrative Medicine, 2007
- Panax ginseng.2003
- Evaluating health utility in patients with melanoma, breast cancer, colon cancer, and lung cancer: a nationwide, population-based assessmentJournal of Surgical Research, 2003
- Cancer-Related Fatigue: Prevalence of Proposed Diagnostic Criteria in a United States Sample of Cancer SurvivorsJournal of Clinical Oncology, 2001